Results 191 to 200 of about 5,331,188 (312)

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Social inequalities in return-to-work among colorectal cancer survivors in Germany. [PDF]

Support Care Cancer
Soff J, Demirer I, Sibert NT, Breidenbach C, Ernstmann N, Heidkamp P, Heier L, Hiltrop K, Schellack SK, Weiß J, Rick O, Benz SR, Dragano N, Kowalski C.   +13 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Stakeholder Perspectives on Cancer Survivors' Return to Work and Well-Being: Qualitative Interview Study. [PDF]

JMIR Cancer
Fällman SL, Wijk K, Efverman A, Eklund L, Fessé P, Trygged S, Fjell M.   +6 more
europepmc   +1 more source

Problem Drinking in Cancer Survivors [PDF]

Korean Journal of Family Medicine, 2020
openaire   +2 more sources

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Long-Term Survival Disparities by Race and Ethnicity Among Cancer Survivors in United States. [PDF]

Cancer Med
Cheng HG, Hong S, Palesh O, Aduse-Poku L, Martins R, Winn RA, Tossas KY.   +6 more
europepmc   +1 more source

American College of Sports Medicine roundtable on exercise guidelines for cancer survivors.

Medicine & Science in Sports & Exercise, 2010
K. Schmitz, K. Courneya, Charles Matthews, W. Demark-Wahnefried, D. Galvão, B. Pinto, M. Irwin, K. Wolin, R. Segal, A. Lucia, C. Schneider, V. V. von Gruenigen, A. Schwartz   +12 more
semanticscholar   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Gamification Boosts Physical Activity in Disparate Populations of Cancer Survivors. [PDF]

JACC CardioOncol
Zhao S.
europepmc   +1 more source